[University home]

Imaging Facilities

PET Radiochemistry

WMIC has an active radiotracer development programme which aims to expand our portfolio of available tracers. This programme uses our extensive radiochemistry facilities to produce to GMP standards for clinical studies as well as experimental tracers for pre-clinical studies.

If you would like to discuss any of the radiotracers shown in the table below, or other possibilities, please contact Gavin Brown.

Tracer Used to study Status
[15O] Water Blood flow GMP online
[15O] Carbon Monoxide Blood volume GMP online
[18F] FDG Glucose metabolism GMP online
[11C] PK11195 Peripheral benzodiazepine binding site GMP online
[11C] MDL 100,907 Serotonin 5-HT2A receptor GMP online
[11C] DASB Serotonin transporter GMP online
[11C] Antisense compound Apoptosis GMP online
[18F] FLT Proliferation GMP online
[11C] Methionine Protein synthesis GMP online
[11C] Verapamil P-glycoprotein transporter GMP online
[18F] Proprietory amyloid tracer Amyloid plaque GMP online
[11C] Diprenorphine Non-subtype selective opiate receptor GMP online
[18F] labelling of generic macromolecules Various non-GMP online
[18F] DPA-713/714 Peripheral benzodiazepine binding site non-GMP online
[18F] Interleukin-1RA Neuro-inflammation non-GMP online
[18F] F-DOPA Dopamine synthesis GMP online
[18F] MISO Hypoxia In development
[18F] Fluorocholine Cellular phospholipid synthesis GMP online
[18F] Sodium Fluoride Bone scanning GMP online

 

Some of our tracers are available for distribution. For more information please contact Jonathan Bevan.